US › Healthcare

NovaBridge Biosciences (NBP)

US · Healthcare · Biotechnology

$1.65+2.48%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit
$-4.4M
Profit YoY
-39.7%
EPS
$-0.04
EPS estimate
$-0.12

EPS came in at -0.04 against a street estimate of -0.12 — a beat of 66.7%.

Key statistics

Market cap
$185.0M
Forward P/E
2.7
P/B
0.81
Book value
$2.00
EPS (TTM)
$-0.49
52-week high
$6.79
52-week low
$1.46
50-day MA
$1.74
200-day MA
$3.06
Beta
1.45

Analyst view

with an average price target of $8.00.

Shareholding

Insiders
14.41%
Institutions
39.87%

Largest institutional holders

FundStake
HHG PLC5.22%
Hillhouse Capital Advisors, Ltd.5.17%
Morgan Stanley - Brokerage Accounts3.32%
Siren, L.L.C.2.59%
AIHC Capital Management Limited1.96%
Point72 Asset Management, L.P.1.20%
Candriam Luxembourg S.C.A.0.98%
Adage Capital Partners Gp LLC0.86%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for NovaBridge Biosciences — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.